Why the study?
What are the risk factors for and prognostic value of venous thromboembolism in patients with advanced non-small cell lung cancer?
What are the risk factors for and prognostic value of venous thromboembolism in patients with advanced non-small cell lung cancer?
In patients with advanced NSCLC, VTE is associated with specific clinical risk factors (weight loss, poor PS, increased CRP, prolonged PT) and indicates a poorer prognosis.
May warrant VTE surveillance in advanced NSCLC with these factors; leaves open whether prophylaxis alters prognosis.
The incidence of VTE was high among advanced NSCLC patients, particularly for those with weight loss, poor PS, increased CRP and long PT. Moreover, the patients with VTE complications may have a poorer prognosis.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: